Glycopyrrolate Injection
Product Images NDC 71872-7224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7224-1.pdp (71872 7224 1)

71872-7224-1.pdp (71872 7224 1)
This is a description of Glycopyrrolate Injection, a medication solution in a single-dose vial intended for intramuscular or intravenous administration. The package has clear instructions for use and dosage, as well as storage conditions. However, it notes that it is not suitable for newborns and contains alcohol. The manufacturer listed is Xrormad, LLC.*
FDA Label Image

Glycopyrrolate-spl-1ml-container-label (Glycopyrrolate Spl 1ml Container Label)

Glycopyrrolate-spl-1ml-container-label (Glycopyrrolate Spl 1ml Container Label)
Glycopyrrolate Injection is a prescription medicine that is used for intramuscular or intravenous administration. It is available as single-dose vials of 1 mL and contains Benzyl Alcohol. The product is manufactured in India and distributed by Xiromed LLC. The lot number, manufacturing date and other details are printed on the packaging.*
FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.